Tyrosine kinase inhibitor neratinib attenuates liver fibrosis by targeting activated hepatic stellate cells

por Park, Yong Joo, An, Hyoung-Tae, Park, Jong-Sung, Park, Ogyi, Duh, Alexander J., Kim, Kwangmeyung, Chung, Kyu Hyuck, Lee, Kang Choon, Oh, Yumin, Lee, Seulki
Publicado 2020